Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 AUD | +9.38% | +11.11% | +47.37% |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Apr. 04 | Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 796M 517M |
---|---|---|---|---|---|
Net income 2024 * | -37M -24.05M | Net income 2025 * | -47M -30.55M | EV / Sales 2024 * | - |
Net cash position 2024 * | 131M 85.03M | Net cash position 2025 * | 86.71M 56.36M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-19.4
x | P/E ratio 2025 * |
-16.2
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.27% |
1 day | +9.38% | ||
1 week | +11.11% | ||
Current month | +1.82% | ||
1 month | +0.72% | ||
3 months | +15.23% | ||
6 months | +177.23% | ||
Current year | +47.37% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 2.8 | +9.38% | 2 115 368 |
24-04-29 | 2.56 | +1.19% | 511,765 |
24-04-26 | 2.53 | -2.69% | 256,117 |
24-04-24 | 2.6 | +3.17% | 851,962 |
24-04-23 | 2.52 | -3.08% | 780,961 |
Delayed Quote Australian S.E., April 30, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.37% | 522M | |
-2.79% | 102B | |
+1.42% | 96.29B | |
+1.60% | 22.18B | |
-16.44% | 21.2B | |
-9.84% | 18.31B | |
-38.74% | 17.38B | |
-14.48% | 16.36B | |
+5.02% | 13.97B | |
+32.85% | 12.17B |
- Stock Market
- Equities
- CU6 Stock